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Abstract
Major depressive disorder (MDD) has been associated with abnormal prefrontal-limbic interactions and altered
catecholaminergic neurotransmission. The val158met polymorphism on the catechol-O-methyltransferase (COMT)
gene has been shown to influence prefrontal cortex (PFC) activation during both emotional processing and working
memory (WM). Although COMT-genotype is not directly associated with MDD, it may affect MDD pathology by
altering PFC activation, an endophenotype associated with both COMT and MDD. 125 participants, including healthy
controls (HC, n=28) and MDD patients were genotyped for the COMT val158met polymorphism and underwent
functional magnetic resonance imaging (fMRI-neuroimaging) during emotion processing (viewing of emotional facial
expressions) and a WM task (visuospatial planning). Within HC, we observed a positive correlation between the
number of met-alleles and right inferior frontal gyrus activation during emotional processing, whereas within patients
the number of met-alleles was not correlated with PFC activation. During WM a negative correlation between the
number of met-alleles and middle frontal gyrus activation was present in the total sample. In addition, during
emotional processing there was an effect of genotype in a cluster including the amygdala and hippocampus. These
results demonstrate that COMT genotype is associated with relevant endophenotypes for MDD. In addition, presence
of MDD only interacts with genotype during emotional processing and not working memory.
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Introduction
Major depressive disorder (MDD) is a disorder characterized
by abnormal interactions between cortical and subcortical
structures [1,2] and altered catecholamine neurotransmission
[3,4]. These disturbances affect both emotion processing [2]
and executive functioning [5], and MDD is characterized by
abnormal prefrontal activation during tasks tapping into these
functions [2,5-12].
Catecholaminergic neurotransmission plays a central role in
emotional and cognitive processing and it has recently been
hypothesized that abnormal dopamine levels in the striatum
contribute to altered cortical-subcortical interactions in MDD [2].
Catechol-O-methyltransferase (COMT) is an enzyme that
breaks down catecholamines such as dopamine and
norepinephrine, and is mainly present in prefrontal and
temporal cortical areas [13,14]. A common polymorphism in the
COMT-gene (i.e. rs4680, val158met; leading to an amino acid
change of valine [val] to methionine [met]) results in altered
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COMT activity. Met-homozygotes have a three to four fold
lower activity of COMT compared to val-homozygotes, with
heterozygotes showing intermediate levels [15].
Consequentially, met-carriers have higher cortical
concentrations of dopamine [16]. COMT-genotype variability
has been postulated as an evolutionary switch toward a more
cognitive versus a more emotional mental processing style
[17].
In a meta-analysis investigating the effects of val158met
genotype on prefrontal cortex (PFC) activation, it was shown
that during emotional processing tasks the number of met-
alleles correlated positively with PFC activation [18], located
primarily in the inferior frontal gyrus (BA 45 and 47) [19-21].
This finding was interpreted as less efficient processing in met-
carriers [18]. In contrast, during working memory tasks the
number of met-alleles was negatively correlated with activation
in the middle and superior frontal gyri (BA 9 and 46) [22-26]
and IFG [27,28], implying less efficient processing in val-
carriers in analogy with Mier et al. [18].
In addition to the PFC, during negative emotional processing,
COMT-genotype has also shown to have an effect on
amygdala activation. However, the results regarding the
direction of the effect are inconsistent. Some studies reported a
positive association between activation and the number of met-
alleles [20,29-31], whereas others showed a negative
[21,32,33] or an absent association [19]. Although the direction
of the effect on the amygdala is not as clear as the effect on
the PFC, there could be an influence of COMT genotype on
amygdala functioning.
A direct association between MDD and val158met genotype
has not been demonstrated [34]. We propose, however, that
PFC and/or amygdala activation might be an endophenotype in
studying the genetic basis of MDD. An endophenotype has
been defined as a (neuro) biological substrate underlying a
disease and to be more closely related to the effects of the
gene [35]. Endophenotypes are often investigated in samples
of healthy participants, but the presence of psychiatric
disorders may modulate the effects of val158met genotype on
brain activation [21,36]. To date, however, such modulatory
effects of MDD on the association between val158met and
regional brain activation has not been investigated.
The main aim of this study was to investigate the interaction
between val158met genotype and depression using PFC and
amygdala activation as endophenotype. For this purpose, we
investigated whether the presence of MDD affected the
opposing effects of genotype on PFC and amygdala activation
during emotional and working memory tasks previously
observed in healthy subjects. We measured brain activation
with the use of fMRI-neuroimaging during a facial expression
task and the “Tower of London” task, which is a visuospatial
planning task known to activate a similar brain network as other
working memory tasks [37]. Because of the variety in findings
of PFC locations related to COMT-genotype [18], the entire
lateral PFC was taken as our region of interest (ROI). The
amygdala was used as an extra ROI in the analysis of the
emotional processing task. In addition, we performed a whole-




Participants were selected from the multicenter Netherlands
Study of Depression and Anxiety (NESDA [38]) which involved
the University Medical Center Groningen (UMCG), VU
University Medical Center, Amsterdam (VUmc) and Leiden
University Medical Center (LUMC).
Exclusion criteria for all participants were presence or history
of major internal and neurological disorder with potential central
nervous system sequelae; current use of a beta-blocker;
hypertension >180/130 mm Hg; age over 57 years; MRI
incompatible implants or tattoos; use of psychotropic
medication other than selective serotonin reuptake inhibitors
(SSRIs) or infrequent use of benzodiazepines (oxazepam or
diazepam, maximum of three times a week and not within 48
hours before scanning); and incomplete MRI data and/or
overall task performance below 75% correct trials on the Tower
of London task to maximize the likelihood of analyzing
planning-related activation. A word encoding and recognition
task [39] was also used as an exclusion criterion, to confirm
task engagement due to the two-choice answer method.
Genotype data were obtained in addition to functional MRI
data during emotional and working memory processing from
125 participants. Of these, 97 had experienced major
depressive disorder (MDD) during their life as established
using the Composite International Diagnostic Interview (CIDI)
[40], and were therefore considered to have the phenotype
depression vulnerability whereas the other 28 were healthy
controls (Table 1 and Table 2). Presence of anxiety diagnosis
was allowed because of the high comorbidity with MDD (n=66),
presence of any other psychiatric disorder was an exclusion
criteria in the overall NESDA study.
Ethic statement
This study was approved by the Ethical Committees at the
University Medical Center Groningen, VU University Medical
Center, Academic Medical Center, Amsterdam, and the Leiden
University Medical Center. All participants provided written
informed consent. The study was conducted in accordance
with the declaration of Helsinki.
Clinical measurements
Depression severity was determined by the Montgomery-
Åsberg rating scale (MADRS) [41] and anxiety severity was
determined by the Beck Anxiety Inventory (BAI) [42].
Genotyping
Genotyping was performed in the context of the genome
wide association (GWA) study of the Genetic Association
Information Network (GAIN), its method having been described
in detail elsewhere [43]. Perlegen Sciences (Mountain View,
CA, USA) performed all genotyping according to standard
operating procedures. High-density oligonucleotide arrays were
used yielding 599,164 single nucleotide polymorphisms (SNP).
These arrays included the val158met SNP (rs4680). In this
sample, the genotype distribution of the rs4680 did not differ
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significantly from the expected numbers calculated on the basis
of observed allele frequencies according to the Hardy-
Weinberg equilibrium (HWE, χ2(1)=0.2, p>.65).
MRI protocol
Emotion processing.  The paradigm used in this study was
described before [44]. Briefly, participants viewed photographs
from a widely used set of emotional facial expressions [45]
(angry, fearful, happy, neutral and sad) and were requested to
Table 2. Demographic and clinical details partitioned
according to diagnoses.
  HC patients test p
N  28 97   
Genotype mm/mv/vv 11/10/7 20/55/22 χ2(2)=4.94 .08
Gender #females (%) 14 (50%) 65 (67%) χ2(1)=2.70 .10
Age mean (SD) 40.93 (8.67) 36.11 (9.99) t(123)=2.31 0.02#
Center UMCG/AMC/LUMC* 8/10/10 38/17/42 χ
2(2)=4.29 .12
Education (in
years) mean (SD) 14.79 (2.50) 12.12 (3.08) t(123)=4.19 <.001#
MADRS mean (SD) 1.25 (1.99) 14.68 (9.33) t(123)=7.55 <.001
BAI mean (SD) 2.14 (2.58) 13.56(10.20) t(123)=5.85 <.001
SSRI use N (%) - 32 (33)   
Faces task - reaction times
(milliseconds)     
angry  813.98(166.37)
829.62
(168.06)   
fear  865.36(168.11)
863.90
(179.33)   
happy  878.66(151.62)
877.72
(168.58)   
neutral  878.16(138.80)
873.41
(169.73)   
sad  852.12(154.50)
864.36
(163.17)   
Tower of London task - reaction times
(seconds)    
step 1  4.51 (1.19) 4.85 (1.48)   
step 2  5.79 (1.62) 6.08 (1.84)   
step 3  8.35 (3.54) 8.00 (2.49)   
step 4  12.33 (4.85) 11.35 (3.77)   
step 5  16.53 (4.52) 16.06 (5.92)   
Tower of London task - accuracy
(proportions)    
step 1  0.96 (0.07) 0.96 (0.05)   
step 2  0.93 (0.08) 0.93 (0.09)   
step 3  0.93 (0.09) 0.93 (0.09)   
step 4  0.84 (0.15) 0.82 (0.17)   
step 5  0.81 (0.14) 0.77 (0.21)   
#for these variables was corrected in the main analyses. * UMCG: University
Medical Center Groningen; AMC: Amsterdam Medical Center; LUMC: Leiden
University Medical Center.
doi: 10.1371/journal.pone.0073290.t002
make gender judgments. Twenty-four stimuli were selected for
each of five facial expressions, comprising 12 female and 12
male faces. Each face was not presented more than four times.
As control condition, a scrambled face with an arrow (“<<” or
“>>”) was shown indicating which button to press. The control
condition (scrambled faces) was presented 80 times. The
pictures were shown for 2.5 seconds. Responses and reaction
times were recorded.
Working memory.  The Tower of London (ToL) task was
used to measure working memory [11,46]. On the screen two
pictures were shown with colored balls on rods, representing
two configurations, one start and one goal. In the task
condition, participants had to work out the number of steps
(ranging from one to five) needed to reach the target
configuration. In the control condition, they were instructed to
count the number of blue and yellow balls. We used a
pseudorandomized, self-paced design with maximal response
duration of 60 seconds for each trial. Responses and reaction
times were recorded.
Image acquisition
All participants were scanned using a Philips 3T MR-scanner
at the three different sites. A SENSE-8 -channel head coil was
used for radio frequency transmission and reception in
Groningen and Leiden. In Amsterdam a SENSE-6 channel
head coil was used.
For every participant, echo planar images (EPI) were
obtained, entailing a T2*weighted gradient echo sequence
using axial whole brain acquisition, with an interleaved slice
acquisition order and the following settings: repetition time (TR)
= 2300 ms, echo time (TE) = 28.0 at UMCG and 30 at AMC
and LUMC, and a flip angle of 90°. At UMCG 39 slices per EPI
volume were acquired, with a matrix size of 64x64 voxels and
an in-plane resolution of 3x3 mm. At AMC and LUMC 35 slices
per EPI volume were acquired, with a matrix size of 96x96
voxels and an in-plane resolution of 2.29x2.29 mm. The slices
had a 0 mm gap and 3 mm thickness. The images were
acquired parallel to the anterior-posterior commissure plane. In
addition, a T1-weighted anatomical MRI was made (TR = 9 ms,
TE = 3.5 ms, matrix size 256x256, voxel size: 1x1x1 mm).
Data analyses
Demographic, clinical and behavioral data.  For the
analysis of clinical and behavioral data SPSS version 16.0 was
used. To test for genotype and presence of psychopathology
effects on demographic data, Chi-square test or analysis of
variance was used, whenever appropriate. To investigate an
association between genotype and depression and anxiety
symptoms, a multivariate analysis of variance (MANOVA) was
performed with genotype as independent variable and MADRS
and BAI-scores as dependent variables.
For behavioral data, repeated measures ANOVAs were used
for reaction times (faces task and TOL) and accuracy (TOL)
with emotional expression as a within-subject factor and
presence of psychopathology and number of met-alleles as
between-subject factors.
Preprocessing of functional data.  Functional imaging data
were preprocessed and analyzed using Statistical Parametric
Effects of COMT on Neural Activation in Depression
PLOS ONE | www.plosone.org 4 September 2013 | Volume 8 | Issue 9 | e73290
Mapping software (SPM5; http://www.fil.ion.ucl.ac.uk/spm/)
implemented in Matlab 7.1.0 [47]. Preprocessing included slice
time correction, image realignment, registration of the T1-scan
to the mean EPI, warping to MNI-space as defined by the
SPM5 T1-template, reslicing to 3×3×3 mm voxels and spatial
smoothing using an 8-mm FWHM Gaussian kernel. Movement
of the participant of >3 mm in any direction resulted in
exclusion of all data from further analysis.
First-level analyses.  For the emotion processing task, for
every participant, hemodynamic responses for each stimulus
were modeled, including regressors for each condition (angry,
fearful, happy, neutral and sad) and for baseline trials
(scrambled faces). Low frequency noise was removed by
applying a high pass filter of 128 s. For each participant,
contrast images were produced for “negative vs. scrambled”,
consisting of the expressions angry, fear and sad and “positive
vs. scrambled”, including happy facial expressions.
For the working memory task, for every participant,
hemodynamic responses for each stimulus were modeled. The
model included regressors for each number of steps and for
baseline items. Again, low frequency noise was removed by
applying a high pass filter of 128 s. For each participant,
contrast images for “task load” [with trial types 1–5 having
weights (-1.5, -1, -0.5, 1, 2)] were calculated.
Second level analyses.  We performed separate factorial
models for each first-level contrast (i.e. negative faces vs.
scrambled, positive faces vs. scrambled, and ‘task load’ (ToL)).
Diagnosis was entered as factor. Comparable to previous
studies (e.g. [20,22,48]), gene-dose of COMT genotype was
entered as regressor, coded as the number of met-alleles (0, 1
or 2). This regressor was modeled in interaction with diagnosis.
To control for potential confounding effects of gender on
genotype, we added gender, center (two dummy variables),
age, education (last two adjusted for the group mean) as
covariates. A small volume correction was used for our regions
of interest (ROIs). Based on the literature (see introduction), we
chose the entire left and right lateral PFC (based on AAL library
implemented in WFU pickatlas: superior frontal gyrus, middle
frontal gyrus, inferior frontal gyrus, medial frontal gyrus, see
also Figure S1) as our ROI (left and right separately). In
addition, for the emotional processing task we also included the
bilateral amygdala as ROI.
We tested for correlations between genotype and PFC
activation independent of diagnosis and differences in these
correlations between HC and patients, all within one model. For
the correlation between number of met-alleles and brain
activation, a threshold was set at p<.05 family wise error (FWE)
cluster-level corrected for the spatial extent of the search
volume of our ROIs. The interaction between genotype and
diagnosis was inspected with an F-test at a threshold of p<.
001. The post-hoc t-tests had to meet p<.05 FWE cluster-level
corrected for the spatial extent of the search volume of our
ROIs. For completeness, we also report whole-brain analyses
at a threshold of p<.05 family wise error (FWE) whole-brain
cluster-level corrected.
We extracted the mean activation of the clusters with the use
of MarsBaR [49] as a measure of the strength of the brain
activation per participant to visualize the data in a scatterplot.
Results
Demographic and Clinical data
Genotype was not related to gender (χ2(2)= 1.50, p=.47), age
(F(2, 122)=1.99, p=.14) or education (F(2, 122)=0.96, p=.34, Table
1). The multivariate ANOVA did not reveal an association
between genotype and MADRS and/or BAI-scores in the total
sample (Pillai’s trace F(4, 244)=1.41, p=.23) or in patients only
(Pillai’s trace F(4, 188)=0.60, p=.66). There was also no significant
association between genotype and diagnosis (χ2(6)=7.12, p=.
31) or genotype and SSRI-use (χ2(2)= 1.87, p=.39, Table 1).
Emotional processing task
Behavioral responses.  A main effect of emotional
expression was present on reaction times (F(4, 114)=5.55, p<.
001): all participants were faster in responding to angry faces
than to other emotional expressions. The number of met-alleles
or presence of psychopathology or interactions between these
variables did not affect RTs, also not in interaction with
emotional expression (all F<1.06, all p>.37).
Neural responses.  There was no significant correlation
between genotype and activation during processing of negative
emotional expressions in the PFC or amygdala in the overall
sample. However, we observed an interaction between
genotype and presence of MDD (Brodmann area [BA] 45,
[x=39 y=39z=18], F(1, 116)=24.74), reflecting a positive
correlation between the number of met-alleles and activation in
the right inferior frontal gyrus (IFG) in HC (BA45, Figure 1,
Z=4.49, k=35, pFWE=.014), which was absent in patients. There
were no significant main effects for diagnosis. However, a trend
was seen of more activation for MDD patients than HC in the
same location as the interaction effect was present ([x=39
y=39z=18], Z=4.12, k=8, pFWE=.19, p<.001 uncorrected).
During processing of positive emotional expressions, there
was no significant correlation between genotype and PFC
activation, also not in interaction with diagnosis. In the left
amygdala, there was a positive correlation between number of
met-alleles and activation in the overall sample ([x=-27
y=-6z=-18], k=2, Z=3.38, pFWE=.036) However, our whole-brain
analysis showed that this activated cluster was mostly located
in the hippocampus (Figure 2, [x=-33 y=-3z=-21], Z=4.06, k=19,
pFWE=.38, whole brain corrected, p<.001 uncorrected). There
were no significant main effects for diagnosis.
After excluding patients using SSRIs the results in the PFC
were highly similar. There were no significant correlations
between number of met-alleles and brain activation in response
to the contrasts “negative vs. neutral expressions” or “positive
vs. neutral expressions”.
Working memory task
Behavioral responses.  With increasing difficulty of the task
(increase in number of steps), reaction times (RTs) became
longer (F(1.71, 203.92)=271.81, p<.001) and accuracy
decreased (F(2.68, 318.74)=34.50, p<.001). There were no
main effects of number of met-alleles or presence of
psychopathology on RT or on accuracy nor in interaction with
Effects of COMT on Neural Activation in Depression
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each other (all F<1.21, p>.30) or in interaction with the number
of steps (all F<0.91, p>.40).
Neural responses.  Over the whole sample, there was a
significant negative association between number of met-alleles
and right middle frontal gyrus (MFG, BA46/10) activation
(Figure 1, [x=33 y=48z=12], k= 34, Z=3.82, pFWE=.024). The
correlation between genotype and PFC activation did not reach
significance within HC (Z=3.16, pFWE=.39, puncorr=.001) or MDD
(Z=3.53, pFWE=.08, puncorr<.001) separately. There was also no
interaction between diagnosis and genotype on PFC activation.
In addition, no other areas emerged as significantly from the
Figure 2.  Hippocampal activation during emotional
processing showing correlations with number of met-
alleles: exploratory analysis.  A. Positive correlation between
the number of met-alleles and activitation in the left
hippocampus/amygdala. A threshold was set at p<.001
uncorrected.
doi: 10.1371/journal.pone.0073290.g002
whole-brain analysis. Excluding medicated patients did not
change these results.
Discussion
The aim of the current study was to investigate the influence
of the val158met polymorphism in the gene coding for
catechol-O-methyltransferase (COMT) on cortical functioning,
and whether the presence of major depressive disorder (MDD)
moderated these associations. Met-homozygotes have been
associated with lower enzymatic activity of COMT compared to
val-homozygotes [15], with consequently higher cortical
dopamine concentrations [16]. We showed that during
emotional processing there was an interaction between
diagnosis and COMT-genotype: in healthy participants the
number of met-alleles was associated with higher activation in
the inferior frontal gyrus (IFG), whereas in MDD patients IFG
activation was not affected by genotype. In addition, during
working memory, carrying the met-allele was associated with
lower activation in the middle frontal gyrus (MFG) in both HC
and MDD patients. Thus, our results show a more extensive
moderating effect of MDD on the relation between COMT
genotype and PFC activation during emotional processing than
during working memory.
A moderating effect was present of psychopathological
status on the effect of val158met genotype on IFG (BA45)
activation during processing of negative facial expressions.
Within healthy participants the number of met-alleles was
positively correlated with activation in the IFG, whereas within
patients, there was no effect of val158met genotype in IFG
activation. The IFG has been associated with emotional
processing [50] and behavioral inhibition [51,52]. In addition,
greater activation in this area has also been associated with
inhibition of negative emotions [6,50,53]. It has been suggested
that met/met-carriers show impairments in emotion paradigms
in combination with more PFC activation, reflecting less
efficient cortical functioning [18]. This might be associated with
less efficient inhibition of emotional distraction due to negative
Figure 1.  Prefrontal cortical activity correlated with number of met-alleles during emotional and working memory
processing: hypothesis testing.  Red represents a positive correlation between number of met-alleles during processing of
negative emotional facial expressions only in HC. The graph depicting the correlation between activity and number of met-alleles is
located on the left. Blue represents a negative correlation between number of met-alleles and activity during working memory over
all subjects. The graph depicting the correlation between activity and number of met-alleles is located on the right. The threshold
was set at p<.001 uncorrected and the peak voxel had to survive p<.05 family wise error (FWE) corrected for the spatial extent of
the PFC with a small volume correction (see methods).
doi: 10.1371/journal.pone.0073290.g001
Effects of COMT on Neural Activation in Depression
PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e73290
facial expressions. In our sample, healthy met/met-genotype
carriers showed more activation in the IFG, but did not show
any difference in behavioral responses. Therefore,
hyperactivation of the IFG might represent a compensation
mechanism to reach the same level of functioning. Within
patients, there was no effect of val158met genotype in IFG
activation; the met/met-carriers showed a similar response as
val/val-carriers, but in general lower than HC. It could be
suggested that the effects of depression on brain activation
during emotional processing are greater than the effects of
COMT-genotype, obscuring any compensatory activation in
depressed met/met-carriers as was found in healthy
participants.
Depression is primarily a disorder of emotion [54]. Therefore,
it is an interesting finding that the interaction with
psychopathology was only present during emotional
processing. During working memory, there was less activation
in the MFG related to the met-allele in both patients and
healthy controls. This was accompanied by an absence of
performance differences, indicating that WM processing was
intact. The task was probably not too easy, given the increase
in reaction times and decrease in accuracy with increasing
planning load. The direction of the effect of val158met
genotype on brain activation is in line with the meta-analysis of
Mier et al. (2010) and suggests a compensation in cortical
processing in val/val-carriers during working memory. In
addition, the absent of an interaction with psychopathology, is
in agreement with other studies showing normal planning
performance in MDD outpatients, suggesting relatively
unaffected cognitive functioning [11,55-57]. Notably,
impairments in working memory are particularly present in
severely depressed patients (reviewed by [58,59]), whereas
emotional processing is thought to be disturbed already before
the onset of the first depressive episode (reviewed by [60,61]).
This could explain that psychopathological status of our
relatively mild depressed outpatient sample moderated the
effect of genotype only during emotional processing and not
during working memory.
In addition to the prefrontal cortex, during processing of
positive emotional facial expressions, there was a positive
correlation between the number of met-alleles and activitation
in the amygdala. However, these voxels were part of a larger
cluster, which was mostly located in the hippocampus.
Therefore, the effect in the amygdala likely represents a partial
volume effect from the hippocampal activation. Besides the
cortex, COMT is also strongly expressed in the hippocampal
formation, especially the dentate gyrus [13]. Indeed, there are
previous reports of positive correlations between number of
met-alleles and hippocampal activity during memory
processing [62-64] and also one report of a positive correlation
between the number of met-alleles and activitation in the left
hippocampus during processing of unpleasant stimuli [20].
However, to our knowledge, our results show for the first time
an association between COMT-genotype and activation in the
hippocampus in response to positive emotional stimuli.
Although the hippocampus has primarily been associated with
memory processing, it has also been associated with inhibition
of stress responses (e.g. [65]) and emotion processing [66]. As
described above, it has been suggested that met/met-carriers
are less emotionally stable [17]. This might lead to a
compensation in brain activation in a broader network of
emotion processing related brain areas, including the prefrontal
cortex [18] and subcortical areas.
A limitation of this study was the relatively small sample size,
which does not allow for strong conclusions on genetic
associations. In addition, there were many variables in our
sample that could have been confounding factors (e.g.
medication use, scanner site). For all effects, we have tested
for a possible influence of these confounding factors. Despite
not finding any influence of these possible confounders, such
effects cannot be fully discarded due to our limited sample size.
Not with standing, we think our findings are of interest as this is
the first study that replicates the meta-analysis results of Mier
et al. and their hypothesis of current literature on pleiotropic
effects of val158met genotype on PFC activation in one single
sample. In addition, this is to our knowledge one of the first
studies to suggest that this effect is moderated by
psychopathology.
To conclude, these results showed that the influence of
COMT val158met genotype on prefrontal function is different in
depressed patients compared to HC during emotional
processing, but not during WM. This SNP thus appears to play
a role in the etiology or expression of MDD or both with brain
activation as a promising endophenotype. In addition, our study
revealed that COMT-genotype influenced activation during
emotional processing in subcortico-limbic areas (VTA and
hippocampus). It could be speculated that increased activation
in these areas in met-carriers may contribute to less emotional
resilience and render carriers more vulnerable to affective
disorders.
Supporting Information
Figure S1.  Definition of regions of interest. The left (red)
and right (blue) prefrontal cortex were selected as our regions
of interest based on the automatic atlas library regions:
superior frontal gyrus, middle frontal gyrus, inferior frontal
gyrus, medial frontal gyrus. The orbital part of the PFC was
omitted due to scanner artefacts.
(DOCX)
Acknowledgements
We would like to thank Dr. L.R. Demenescu and Ms. E.J.
Liemburg for their help with data acquisition, patient
management and Ms. A. Sibeijn-Kuiper for operating the MRI
scanner and Dr. R. Renken for his advice on the analyses.
Author Contributions
Conceived and designed the experiments: DV NvdW MvB BP
AA. Performed the experiments: EO MJvT SW. Analyzed the
data: EO MJvT. Analyzed the data, provided suggestions: RK
DV NvdW AA. Wrote the manuscript: EO. Wrote the
manuscript, provided contributions: RK MJvT NvdW SW MvB
BP DV AA.
Effects of COMT on Neural Activation in Depression
PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e73290
References
1. Mayberg HS (1997) Limbic-cortical dysregulation: A proposed model of
depression. J Neuropsychiatry Clin Neurosci 9: 471-481. PubMed:
9276848.
2. Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF et al. (2012)
Functional neuroimaging of major depressive disorder: A meta-analysis
and new integration of base line activation and neural response data.
Am J Psychiatry 169: 693-703. doi:10.1176/appi.ajp.2012.11071105.
PubMed: 22535198.
3. Dunlop BW, Nemeroff CB (2007) The role of dopamine in the
pathophysiology of depression. Arch Gen Psychiatry 64: 327-337. doi:
10.1001/archpsyc.64.3.327. PubMed: 17339521.
4. Schildkraut JJ (1965) The catecholamine hypothesis of affective
disorders: A review of supporting evidence. Am J Psychiatry 122:
509-522. PubMed: 5319766.
5. Elliott R, Baker SC, Rogers RD, O’Leary DA, Paykel ES et al. (1997)
Prefrontal dysfunction in depressed patients performing a complex
planning task: A study using positron emission tomography. Psychol
Med 27: 931-942. doi:10.1017/S0033291797005187. PubMed:
9234470.
6. Johnstone T, van Reekum CM, Urry HL, Kalin NH, Davidson RJ (2007)
Failure to regulate: Counterproductive recruitment of top-down
prefrontal-subcortical circuitry in major depression. J Neurosci 27:
8877-8884. doi:10.1523/JNEUROSCI.2063-07.2007. PubMed:
17699669.
7. van Wingen GA, van Eijndhoven P, Tendolkar I, Buitelaar J, Verkes RJ
et al. (2011) Neural basis of emotion recognition deficits in first-episode
major depression. Psychol Med 41: 1397-1405. doi:10.1017/
S0033291710002084. PubMed: 21054920.
8. Fitzgerald PB, Srithiran A, Benitez J, Daskalakis ZZ, Oxley TJ et al.
(2008) An fMRI study of prefrontal brain activation during multiple tasks
in patients with major depressive disorder. Hum Brain Mapp 29:
490-501. doi:10.1002/hbm.20414. PubMed: 17525987.
9. Goethals I, Audenaert K, Jacobs F, Van de Wiele C, Ham H et al.
(2005) Blunted prefrontal perfusion in depressed patients performing
the tower of london task. Psychiatry Res 139: 31-40. doi:10.1016/
j.pscychresns.2004.09.007. PubMed: 15927455.
10. Matsuo K, Glahn DC, Peluso MA, Hatch JP, Monkul ES et al. (2007)
Prefrontal hyperactivation during working memory task in untreated
individuals with major depressive disorder. Mol Psychiatry 12: 158-166.
doi:10.1038/sj.mp.4001894. PubMed: 16983390.
11. van Tol MJ, van der Wee NJ, Demenescu LR, Nielen MM, Aleman A et
al. (2011) Functional MRI correlates of visuospatial planning in out-
patient depression and anxiety. Acta Psychiatr Scand 124: 284.
PubMed: 21480834.
12. Wagner G, Sinsel E, Sobanski T, Köhler S, Marinou V et al. (2006)
Cortical inefficiency in patients with unipolar depression: An event-
related FMRI study with the stroop task. Biol Psychiatry 59: 958-965.
doi:10.1016/j.biopsych.2005.10.025. PubMed: 16458263.
13. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM et al. (2003)
Catechol O-methyltransferase mRNA expression in human and rat
brain: Evidence for a role in cortical neuronal function. Neuroscience
116: 127-137. doi:10.1016/S0306-4522(02)00556-0. PubMed:
12535946.
14. Hong J, Shu-Leong H, Tao X, Lap-Ping Y (1998) Distribution of
catechol-O-methyltransferase expression in human central nervous
system. Neuroreport 9: 2861-2864. doi:
10.1097/00001756-199808240-00033. PubMed: 9760135.
15. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL et al.
(1996) Human catechol-O-methyltransferase pharmacogenetics:
Description of a functional polymorphism and its potential application to
neuropsychiatric disorders. Pharmacogenetics 6: 243-250. doi:
10.1097/00008571-199606000-00007. PubMed: 8807664.
16. Tunbridge EM, Harrison PJ, Weinberger DR (2006) Catechol-o-
methyltransferase, cognition, and psychosis: Val158Met and beyond.
Biol Psychiatry 60: 141-151. doi:10.1016/j.biopsych.2005.10.024.
PubMed: 16476412.
17. Stein DJ, Newman TK, Savitz J, Ramesar R (2006) Warriors versus
worriers: The role of COMT gene variants. CNS Spectr 11: 745-748.
PubMed: 17008817.
18. Mier D, Kirsch P, Meyer-Lindenberg A (2010) Neural substrates of
pleiotropic action of genetic variation in COMT: A meta-analysis. Mol
Psychiatry 15: 918-927. doi:10.1038/mp.2009.36. PubMed: 19417742.
19. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS et
al. (2006) Catechol O-methyltransferase val158met genotype and
neural mechanisms related to affective arousal and regulation. Arch
Gen Psychiatry 63: 1396-1406. doi:10.1001/archpsyc.63.12.1396.
PubMed: 17146014.
20. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H et al. (2005)
Catechol-O-methyltransferase val158met genotype affects processing
of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci
25: 836-842. doi:10.1523/JNEUROSCI.1792-04.2005. PubMed:
15673663.
21. Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P et al. (2011)
The impact of the Val158Met catechol-O-methyltransferase genotype
on neural correlates of sad facial affect processing in patients with
bipolar disorder and their relatives. Psychol Med 41: 779-788. doi:
10.1017/S0033291710001431. PubMed: 20667170.
22. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM et al.
(2001) Effect of COMT Val108/158 met genotype on frontal lobe
function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:
6917-6922. doi:10.1073/pnas.111134598. PubMed: 11381111.
23. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A et al. (2003)
Catechol O-methyltransferase val158-met genotype and individual
variation in the brain response to amphetamine. Proc Natl Acad Sci U S
A 100: 6186-6191. doi:10.1073/pnas.0931309100. PubMed: 12716966.
24. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A et al. (2006)
Additive effects of genetic variation in dopamine regulating genes on
working memory cortical activity in human brain. J Neurosci 26:
3918-3922. doi:10.1523/JNEUROSCI.4975-05.2006. PubMed:
16611807.
25. Bertolino A, Di Giorgio A, Blasi G, Sambataro F, Caforio G et al. (2008)
Epistasis between dopamine regulating genes identifies a nonlinear
response of the human hippocampus during memory tasks. Biol
Psychiatry 64: 226-234. doi:10.1016/j.biopsych.2008.02.001. PubMed:
18374902.
26. de Frias CM, Marklund P, Eriksson E, Larsson A, Oman L et al. (2010)
Influence of COMT gene polymorphism on fMRI-assessed sustained
and transient activity during a working memory task. J Cogn Neurosci
22: 1614-1622. doi:10.1162/jocn.2009.21318. PubMed: 19642882.
27. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B et al.
(2006) Impact of complex genetic variation in COMT on human brain
function. Mol Psychiatry 11: 797-877, 10.1038/sj.mp.4001860.
PubMed: 16786032.
28. Bertolino A, Caforio G, Petruzzella V, Latorre V, Rubino V et al. (2006)
Prefrontal dysfunction in schizophrenia controlling for COMT
Val158Met genotype and working memory performance. Psychiatry
Res 147: 221-226. doi:10.1016/j.pscychresns.2006.04.001. PubMed:
16952445.
29. Lonsdorf TB, Golkar A, Lindstöm KM, Fransson P, Schalling M et al.
(2011) 5-HTTLPR and COMTval158met genotype gate amygdala
reactivity and habituation. Biol Psychol 87: 106-112. doi:10.1016/
j.biopsycho.2011.02.014. PubMed: 21356267.
30. Rasch B, Spalek K, Buholzer S, Luechinger R, Boesiger P et al. (2010)
Aversive stimuli lead to differential amygdala activation and connectivity
patterns depending on catechol-O-methyltransferase Val158Met
genotype. NeuroImage 52: 1712-1719. doi:10.1016/j.neuroimage.
2010.05.054. PubMed: 20510373.
31. Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH et al.
(2010) COMT val(108/158)met polymorphism effects on emotional
brain function and negativity bias. Neuroimage 53: 918-925. doi:
10.1016/j.neuroimage.2010.01.084. PubMed: 20139013.
32. Domschke K, Baune BT, Havlik L, Stuhrmann A, Suslow T et al. (2012)
Catechol-O-methyltransferase gene variation: Impact on amygdala
response to aversive stimuli. Neuroimage 60: 2222-2229. doi:10.1016/
j.neuroimage.2012.02.039. PubMed: 22387174.
33. Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J et al.
(2009) The effects of gender and COMT Val158Met polymorphism on
fearful facial affect recognition: A fMRI study. Int J
Neuropsychopharmacol 12: 371-381. doi:10.1017/
S1461145708009395. PubMed: 18796186.
34. López-León S, Janssens AC, Ladd Gonzalez-Zuloeta AM, Del-Favero
J, Claes SJ et al. (2008) Meta-analyses of genetic studies on major
depressive disorder. Mol Psychiatry 13: 772-785. doi:10.1038/sj.mp.
4002088. PubMed: 17938638.
35. Cannon TD, Keller MC (2006) Endophenotypes in the genetic analyses
of mental disorders. Annu Rev Clin Psychol 2: 267-290. doi:10.1146/
annurev.clinpsy.2.022305.095232. PubMed: 17716071.
36. Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J et al. (2008)
Influence of the catechol-O-methyltransferase val158met genotype on
amygdala and prefrontal cortex emotional processing in panic disorder.
Psychiatry Res 163: 13-20. doi:10.1016/j.pscychresns.2007.04.016.
PubMed: 18440204.
37. Welsh MC, Satterlee-Cartmell T, Stine M (1999) Towers of hanoi and
london: Contribution of working memory and inhibition to performance.
Effects of COMT on Neural Activation in Depression
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e73290
Brain Cogn 41: 231-242. doi:10.1006/brcg.1999.1123. PubMed:
10590821.
38. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA et al.
(2008) The netherlands study of depression and anxiety (NESDA):
Rationale, objectives and methods. Int J Methods Psychiatr Res 17:
121-140. doi:10.1002/mpr.256. PubMed: 18763692.
39. Van Tol MJ, Demenescu LR, Van der Wee Nic JA, Kortekaas R, Nielen
MMA et al. (2012) fMRI correlates of emotional word encoding and
recognition in depression and anxiety disorders. Biol Psychiatry 71(7):
593-602. doi:10.1016/j.biopsych.2011.11.016. PubMed: 22206877.
40. Andrews G, Peters L (1998) The psychometric properties of the
composite international diagnostic interview. Soc Psychiatry Psychiatr
Epidemiol 33: 80-88. doi:10.1007/s001270050026. PubMed: 9503991.
41. Montgomery SA, Asberg M (1979) A new depression scale designed to
be sensitive to change. Br J Psychiatry 134: 382-389. doi:10.1192/bjp.
134.4.382. PubMed: 444788.
42. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for
measuring clinical anxiety: Psychometric properties. J Consult Clin
Psychol 56: 893-897. doi:10.1037/0022-006X.56.6.893. PubMed:
3204199.
43. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH et al.
(2009) Genome-wide association for major depressive disorder: A
possible role for the presynaptic protein piccolo. Mol Psychiatry 14:
359-375. doi:10.1038/mp.2008.125. PubMed: 19065144.
44. Demenescu LR, Renken R, Kortekaas R, van Tol MJ, Marsman JB et
al. (2011) Neural correlates of perception of emotional facial
expressions in out-patients with mild-to-moderate depression and
anxiety. A multicenter fMRI study. Psychol Med: 1-12.
45. Lundqvist D, Flykt A, Ohmann A (1998) The karolinska directed
emotional faces (KDEF). Stockholm: Karolinska Institute.
46. van den Heuvel OA, Groenewegen HJ, Barkhof F, Lazeron RH, van
Dyck R et al. (2003) Frontostriatal system in planning complexity: A
parametric functional magnetic resonance version of tower of london
task. NeuroImage 18: 367-374. doi:10.1016/S1053-8119(02)00010-1.
PubMed: 12595190.
47. the MathWorks Inc. Matlab, 7.1. Natick, MA, USA
48. Swart M, Bruggeman R, Laroi F, Alizadeh BZ, Kema I et al. (2011)
COMT Val158Met polymorphism, verbalizing of emotion and activation
of affective brain systems. NeuroImage 55: 338-344. PubMed:
21156209.
49. Brett M, Anton JL, Valabregue R, Poline JB (2002) Region of interest
analysis using an SPM toolbox [abstract] presented at the 8th
international conference on functional mapping of the human brain.
NeuroImage 16.
50. Dolcos F, LaBar KS, Cabeza R (2004) Dissociable effects of arousal
and valence on prefrontal activity indexing emotional evaluation and
subsequent memory: An event-related fMRI study. NeuroImage 23:
64-74. PubMed: 15325353.
51. van der Meer L, Groenewold NA, Nolen WA, Pijnenborg M, Aleman A
(2011) Inhibit yourself and understand the other: Neural basis of distinct
processes underlying theory of mind. NeuroImage 56: 2364-2374.
PubMed: 21440642.
52. Aron AR, Robbins TW, Poldrack RA (2004) Inhibition and the right
inferior frontal cortex. Trends Cogn Sci 8: 170-177. PubMed:
15050513.
53. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S et al.
(2004) For better or for worse: Neural systems supporting the cognitive
down- and up-regulation of negative emotion. NeuroImage 23:
483-499. PubMed: 15488398.
54. Paykel ES (2008) Basic concepts of depression. Dialogues Clin
Neurosci 10: 279-289. PubMed: 18979941.
55. Castaneda AE, Suvisaari J, Marttunen M, Perala J, Saarni SI et al.
(2008) Cognitive functioning in a population-based sample of young
adults with a history of non-psychotic unipolar depressive disorders
without psychiatric comorbidity. J Affect Disord 110: 36-45. PubMed:
18279972.
56. Porter RJ, Gallagher P, Thompson JM, Young AH (2003)
Neurocognitive impairment in drug-free patients with major depressive
disorder. Br J Psychiatry 182: 214-220. PubMed: 12611784.
57. Purcell R, Maruff P, Kyrios M, Pantelis C (1997) Neuropsychological
function in young patients with unipolar major depression. Psychol Med
27: 1277-1285. PubMed: 9403899.
58. Snyder HR (2012) Major depressive disorder is associated with broad
impairments on neuropsychological measures of executive function: A
meta-analysis and review. Psychol Bull.
59. McDermott LM, Ebmeier KP (2009) A meta-analysis of depression
severity and cognitive function. J Affect Disord 119: 1-8. PubMed:
19428120.
60. Bistricky SL, Ingram RE, Atchley RA (2011) Facial affect processing
and depression susceptibility: Cognitive biases and cognitive
neuroscience. Psychol Bull 137: 998-1028. PubMed: 21895353.
61. Leppänen JM (2006) Emotional information processing in mood
disorders: A review of behavioral and neuroimaging findings. Curr Opin
Psychiatry 19: 34-39. PubMed: 16612176.
62. Bertolino A, Rubino V, Sambataro F, Blasi G, Latorre V et al. (2006)
Prefrontal-hippocampal coupling during memory processing is
modulated by COMT val158met genotype. Biol Psychiatry 60:
1250-1258. PubMed: 16950222.
63. Krach S, Jansen A, Krug A, Markov V, Thimm M et al. (2010) COMT
genotype and its role on hippocampal-prefrontal regions in declarative
memory. Neuroimage 53: 978-984. PubMed: 20060911.
64. Di Giorgio A, Caforio G, Blasi G, Taurisano P, Fazio L et al. (2011)
Catechol-O-methyltransferase val(158)met association with
parahippocampal physiology during memory encoding in
schizophrenia. Psychol Med 41: 1721-1731.
65. Radley JJ, Sawchenko PE (2011) A common substrate for prefrontal
and hippocampal inhibition of the neuroendocrine stress response. J
Neurosci 31: 9683-9695. PubMed: 21715634.
66. Phelps EA (2004) Human emotion and memory: Interactions of the
amygdala and hippocampal complex. Curr Opin Neurobiol 14: 198-202.
Effects of COMT on Neural Activation in Depression
PLOS ONE | www.plosone.org 9 September 2013 | Volume 8 | Issue 9 | e73290
